Breakthrough Therapy Brings New Hope for Chronic Autoimmune Disease Sufferers In a groundbreaking medical development, five lupus patients in England have achieved remission after undergoing a revolutionary therapy that genetically modifies their T-cells, a type of white blood cell crucial for fighting off infections and damaged cells. The innovative CAR (chimeric antigen receptor) T-cell therapy involves removing the patient's T-cells, engineering them to recognize and destroy disease-causing cells, and then reinfusing them into the body. This pioneering approach has the potential to offer a cure for chronic autoimmune diseases like lupus, where the immune system mistakenly attacks healthy tissues, causing debilitating symptoms and long-term damage. If successful, this therapy could provide a new lease on life for millions of people worldwide affected by these debilitating conditions.
Doctors say therapy that genetically modifies person’s T-cells could offer cure for chronic autoimmune diseaseFive lupus patients in England are in remission after being treated with a revolutionary therapy that genetically modifies their own cells, in a medical breakthrough that could offer people a cure, doctors have said.CAR (chimeric antigen receptor) T-cell therapy involves removing a type of white blood cell also called T lymphocytes, which are crucial for hunting out infected or damaged cells, and engineering them to spot and destroy disease. The T-cells are then fed back into the patient via an infusion to reset their immune system. Continue reading...
